Skip to main content
. 2024 Aug 13;11(11):1421–1426. doi: 10.1002/mdc3.14188

Figure 1.

Figure 1

Summary of the blinded and open‐label phases of the lateralized STN‐DBS study. 1 Dashed red line: Average values of the bilateral‐STN‐DBS periods. White arrows: Medication adjustments. Black arrows: Treatment failures. Green arrows: Left‐sided amplitude reduction beneficial. Blue arrows: Right‐sided amplitude reduction beneficial.